Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Hormones and genes affect hair growth and male baldness.

Mice with human gene experienced hair loss when treated with DHT.

Mutations in certain receptors can cause diseases and offer new treatment options.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Certain natural compounds called terpenes may help prevent prostate cancer.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Vitamin D and its receptor may help prevent skin cancer.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.